Investor · 1 deal
Every published round Fountain Healthcare Partners took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Inflazome | Unnamed stage | 17 Dec 2018 | $63m | Participant | SmartCompany (Mon 17 Dec 2018), SmartCompany (Tue 4 Dec 2018) |
Companies Fountain Healthcare Partners has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Inflazome | 17 Dec 2018 | 1 | 0 |
Fund closes reported for Fountain Healthcare Partners, as distinct from the investments it has made.
Companies Fountain Healthcare Partners has backed that another company then bought. An exit for the holding, not a deal Fountain Healthcare Partners did.
Stories naming Fountain Healthcare Partners. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Queensland biotech firm Inflazome has secured a large funding round led by Forbian to advance its anti-inflammatory drug candidates into clinical trials, and has hired a chief medical officer to lead that development.
Also SmartCompany